(Q42546478)

2 November 2017

title

Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood (English)

1 reference

2 November 2017

1 reference

K Rick

1

1 reference

2 November 2017

R Sroka

2

1 reference

2 November 2017

H Stepp

3

1 reference

2 November 2017

M Kriegmair

4

1 reference

2 November 2017

R M Huber

5

1 reference

2 November 2017

K Jacob

6

1 reference

2 November 2017

R Baumgartner

7

1 reference

2 November 2017

publication date

1 October 1997

1 reference

Journal of Photochemistry and Photobiology B

2 November 2017

published in

1 reference

2 November 2017

volume

40

1 reference

2 November 2017

issue

3

1 reference

2 November 2017

page(s)

313-319

1 reference

The metabolism of delta -aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N.

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

Porphyrins, porphyrias, cancer and photodynamic therapy--a model for carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

Pharmacokinetics of 5-aminolevulinic-acid-induced porphyrins in tumour-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin.

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

Detection of early stages of carcinogenesis in adenomas of murine lung by 5-aminolevulinic acid-induced protoporphyrin IX fluorescence.

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

Photodynamic therapy: successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

Photodegradation of protoporphyrin-dimethylester in solution and in organized environments.

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

An Algorithm for Least-Squares Estimation of Nonlinear Parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

Neuropharmacology of delta-aminolaevulinic acid--I. Effect of acute administration in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

Sustained high plasma 5-aminolaevulinic acid concentration in a volunteer: no porphyric symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

Does δ-aminolaevulinic acid induce genotoxic effects?

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

Plasma levels of protoporphyrin IX in humans after oral administration of 5-aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

delta-Aminolaevulinic acid in plasma, cerebrospinal fluid, saliva and erythrocytes: studies in normal, uraemic and porphyric subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

Damage to rat liver mitochondria promoted by delta-aminolevulinic acid-generated reactive oxygen species: connections with acute intermittent porphyria and lead-poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2897%2900076-6

7 January 2021

10.1016/S1011-1344(97)00076-6

Identifiers

DOI

1 reference

2 November 2017

1 reference